Your browser doesn't support javascript.
loading
A Novel Radiogenomics Biomarker for Predicting Treatment Response and Pneumotoxicity From Programmed Cell Death Protein or Ligand-1 Inhibition Immunotherapy in NSCLC.
Chen, Mitchell; Lu, Haonan; Copley, Susan J; Han, Yidong; Logan, Andrew; Viola, Patrizia; Cortellini, Alessio; Pinato, David J; Power, Danielle; Aboagye, Eric O.
Afiliación
  • Chen M; Department of Surgery and Cancer, Imperial College, London, United Kingdom; Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
  • Lu H; Department of Surgery and Cancer, Imperial College, London, United Kingdom.
  • Copley SJ; Department of Surgery and Cancer, Imperial College, London, United Kingdom; Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
  • Han Y; Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
  • Logan A; Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
  • Viola P; North West London Pathology, Charing Cross Hospital, London, United Kingdom.
  • Cortellini A; Department of Surgery and Cancer, Imperial College, London, United Kingdom; Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
  • Pinato DJ; Department of Surgery and Cancer, Imperial College, London, United Kingdom; Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
  • Power D; Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
  • Aboagye EO; Department of Surgery and Cancer, Imperial College, London, United Kingdom. Electronic address: eric.aboagye@imperial.ac.uk.
J Thorac Oncol ; 18(6): 718-730, 2023 06.
Article en En | MEDLINE | ID: mdl-36773776
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos